SB-02024

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSB-02024
Drug Alias NameSB-02024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsImmunostimulantsAutophagy inhibitors
TargetsPI3-kinase class I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSprint Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesSprint BioscienceDeciphera
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A